Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study

BACKGROUND: Two recent randomized controlled trials of type 2 diabetes mellitus (T2DM) patients with history of, or at high risk for, cardiovascular disease (CVD) showed no risk of ischemic cardiovascular events associated with dipeptidyl peptidase-4 inhibitors (DPP4i) but an increased risk of heart...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Acta Diabetol
Main Authors: Kim, Seoyoung C., Glynn, Robert J., Liu, Jun, Everett, Brendan M., Goldfine, Allison B.
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4241160/
https://ncbi.nlm.nih.gov/pubmed/25311055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00592-014-0663-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker